Antiobesity effects of green tea catechins: a mechanistic review

TM Rains, S Agarwal, KC Maki - The Journal of nutritional biochemistry, 2011 - Elsevier
Green tea catechins (GTC) are polyphenolic compounds present in the unfermented dried
leaves of the plant, Camellia sinensis. Results from a number of randomized, controlled …

Pharmacogenetics of antidepressants

C Crisafulli, C Fabbri, S Porcelli, A Drago… - Frontiers in …, 2011 - frontiersin.org
Up to 60% of depressed patients do not respond completely to antidepressants (ADs) and
up to 30% do not respond at all. Genetic factors contribute for about 50% of the AD …

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research

C Fabbri, G Di Girolamo… - American Journal of …, 2013 - Wiley Online Library
Major depressive disorder (MDD) is an emergent cause of personal and socio‐economic
burden, both for the high prevalence of the disorder and the unsatisfying response rate of …

The role of pharmacogenetics in personalizing the antidepressant and anxiolytic therapy

M Radosavljevic, D Svob Strac, J Jancic, J Samardzic - Genes, 2023 - mdpi.com
Pharmacotherapy for neuropsychiatric disorders, such as anxiety and depression, has been
characterized by significant inter-individual variability in drug response and the development …

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy

CA Altar, J Hornberger, A Shewade… - International review of …, 2013 - Taylor & Francis
Adverse events, response failures and medication non-compliance are common in patients
receiving medications for the treatment of mental illnesses. A systematic literature review …

Precision medicine and obesity

A Acosta - Gastroenterology Clinics, 2021 - gastro.theclinics.com
In the last decades, the prevalence of obesity has increased globally, reaching epidemic
proportions. 1 Its worldwide prevalence has almost tripled between 1980 and 2016. 2 In the …

Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence

J Zhu, M Klein‐Fedyshin… - … : The Journal of Human …, 2017 - Wiley Online Library
Selective serotonin reuptake inhibitors (SSRI s) are first‐line pharmacotherapy for mood and
anxiety disorders. The common mechanism of drugs in this class is antagonism of the …

Pharmacogenomics of Medication‐Induced Weight Gain and Antiobesity Medications

S Singh, ML Ricardo‐Silgado, SJ Bielinski, A Acosta - Obesity, 2021 - Wiley Online Library
Obesity is a chronic, multifactorial disease associated with a large number of comorbidities.
The clinical management of obesity involves a stepwise integrated approach, beginning with …

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment

C Fabbri, S Porcelli, A Serretti - The Canadian Journal of …, 2014 - journals.sagepub.com
Objective: Major depressive disorder is the most common psychiatric disorder, worldwide,
yet response and remission rates are still unsatisfactory. The identification of genetic …